1145 related articles for article (PubMed ID: 17149861)
21. Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II).
Kovala-Demertzi D; Hadjipavlou-Litina D; Staninska M; Primikiri A; Kotoglou C; Demertzis MA
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):742-52. PubMed ID: 18720191
[TBL] [Abstract][Full Text] [Related]
22. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
23. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
[TBL] [Abstract][Full Text] [Related]
24. Antitumoral activity of non-platinum xanthate complexes.
Friebolin W; Schilling G; Zöller M; Amtmann E
J Med Chem; 2005 Dec; 48(25):7925-31. PubMed ID: 16335917
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo anticancer activity of copper(I) complexes with homoscorpionate tridentate tris(pyrazolyl)borate and auxiliary monodentate phosphine ligands.
Gandin V; Tisato F; Dolmella A; Pellei M; Santini C; Giorgetti M; Marzano C; Porchia M
J Med Chem; 2014 Jun; 57(11):4745-60. PubMed ID: 24793739
[TBL] [Abstract][Full Text] [Related]
26. Syntheses, characterization and antitumor activities of transition metal complexes with isoflavone.
Chen X; Tang LJ; Sun YN; Qiu PH; Liang G
J Inorg Biochem; 2010 Apr; 104(4):379-84. PubMed ID: 20015553
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.
Primik MF; Göschl S; Jakupec MA; Roller A; Keppler BK; Arion VB
Inorg Chem; 2010 Dec; 49(23):11084-95. PubMed ID: 20979395
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic activity of Gd(III)- and Dy(III)-complexes.
Kostova I; Kiefer W; Momekov G
Arch Pharm (Weinheim); 2007 Dec; 340(12):642-9. PubMed ID: 17994606
[TBL] [Abstract][Full Text] [Related]
29. Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu(I), Au(I)) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line.
Suresh D; Balakrishna MS; Rathinasamy K; Panda D; Mague JT
Dalton Trans; 2008 May; (17):2285-92. PubMed ID: 18414753
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
Coley HM; Sarju J; Wagner G
J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic activity of new neodymium (III) complexes of bis-coumarins.
Kostova I; Manolov I; Momekov G
Eur J Med Chem; 2004 Sep; 39(9):765-75. PubMed ID: 15337289
[TBL] [Abstract][Full Text] [Related]
32. Pyrophosphate-bridged complexes with picomolar toxicity.
Ikotun OF; Higbee EM; Ouellette W; Doyle RP
J Inorg Biochem; 2009 Sep; 103(9):1254-64. PubMed ID: 19666193
[TBL] [Abstract][Full Text] [Related]
33. Three new Cu(II) and Cd(II) complexes with 3-(2-pyridyl)pyrazole-based ligand: syntheses, crystal structures, and evaluations for bioactivities.
Chen R; Liu CS; Zhang H; Guo Y; Bu XH; Yang M
J Inorg Biochem; 2007 Mar; 101(3):412-21. PubMed ID: 17222454
[TBL] [Abstract][Full Text] [Related]
34. Metal complexes with the ligand derived from 6-acetyl-1,3,7-trimethyllumazine and benzohydrazide. Molecular structures of two new Co(II) and Rh(III) complexes and analysis of in vitro antitumor activity.
Jiménez-Pulido SB; Linares-Ordóñez FM; Martínez-Martos JM; Moreno-Carretero MN; Quirós-Olozábal M; Ramírez-Expósito MJ
J Inorg Biochem; 2008 Aug; 102(8):1677-83. PubMed ID: 18538411
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, structure and biological activity of copper(II) complexes of 4-(2-pyridylmethyl)-1,7-dimethyl-1,4,7-triazonane-2,6-dione and 4-(2-pyridylethyl)-1,7-dimethyl-1,4,7-triazonane-2,6-dione.
Singh AP; Kaushik NK; Verma AK; Hundal G; Gupta R
Eur J Med Chem; 2009 Apr; 44(4):1607-14. PubMed ID: 18775587
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antitumor studies on novel Co(II), Ni(II) and Cu(II) metal complexes of bis(3-acetylcoumarin)thiocarbohydrazone.
Sathisha MP; Shetti UN; Revankar VK; Pai KS
Eur J Med Chem; 2008 Nov; 43(11):2338-46. PubMed ID: 18023933
[TBL] [Abstract][Full Text] [Related]
38. Development of cobalt(3,4-diarylsalen) complexes as tumor therapeutics.
Gust R; Ott I; Posselt D; Sommer K
J Med Chem; 2004 Nov; 47(24):5837-46. PubMed ID: 15537341
[TBL] [Abstract][Full Text] [Related]
39. Role of cell cycle events and apoptosis in mediating the anti-cancer activity of a silver(I) complex of 4-hydroxy-3-nitro-coumarin-bis(phenanthroline) in human malignant cancer cells.
Thati B; Noble A; Creaven BS; Walsh M; McCann M; Devereux M; Kavanagh K; Egan DA
Eur J Pharmacol; 2009 Jan; 602(2-3):203-14. PubMed ID: 19041861
[TBL] [Abstract][Full Text] [Related]
40. Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms.
Vock CA; Ang WH; Scolaro C; Phillips AD; Lagopoulos L; Juillerat-Jeanneret L; Sava G; Scopelliti R; Dyson PJ
J Med Chem; 2007 May; 50(9):2166-75. PubMed ID: 17419606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]